C3 ( CTHR ) Diamond in the rough? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : C3 ( CTHR ) Diamond in the rough?

CTHR 0.400

+263.6%

Oct 31 12:16 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Sparkle who wrote (41)	1/7/1998 10:26:00 AM
From: Leslie S. Feinberg	Read Replies (1) of 226

Sparkle; The IPO demand was so strong that the company doubled the number of shares offered. The short term effect was obviously to soften demand. The long term effect is that C3 and Cree Research have much more money to launch the product and set up large scale production facilities. The quality of the product is awsome! The next couple of months will bring significant appreciation to the share price and 12-18 months out the projections of some analysts is for significant profits. Not a bad lead time. Les

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next